Compound research
AOD-9604: Research Overview & Current Status
AOD-9604 is a Growth hormone fragment peptide (hGH 176-191 modified fragment). Current research status: discontinued in clinical development. AOD-9604 completed six human clinical trials (over 900 participants) for obesity between 2001-2007 but development was discontinued in 2007 after a Phase IIb trial failed to show statistically significant weight loss versus placebo. It has never received FDA, EMA, or TGA approval for any indication, and in December 2024 the FDA determined AOD-9604 should not be included on the 503A Bulks List for compounding, citing limited long-term safety data and immunogenicity concerns.
Live vendor pricing
Showing 75 of 75 listings.
Cielo Peptides
Tracked$40.00 / 10mg($40.00 to 10mg)
Checked Aug 8, 2026
Check price at Cielo Peptides →Badger Compounds
Tracked$44.99 / 10mg($44.99 to 10mg)
Checked Aug 15, 2026
Check price at Badger Compounds →LA Peptides
Tracked$49.99 / 10mg($49.99 to 10mg)
Checked May 14, 2026
Check price at LA Peptides →Olympex Solutions
Tracked$29.99 / 5mg($59.98 to 10mg)
Checked Apr 6, 2026
Check price at Olympex Solutions →Premier Research
Tracked$60.00 / 10mg($60.00 to 10mg)
Checked Jul 20, 2026
Check price at Premier Research →Badger Compounds
Tracked$31.99 / 5mg($63.98 to 10mg)
Checked Aug 15, 2026
Check price at Badger Compounds →NextGen Peptides
Tracked$35.00 / 5mg($70.00 to 10mg)
Checked Jul 24, 2026
Check price at NextGen Peptides →Axon Chems
Tracked$70.00 / 10mg($70.00 to 10mg)
Checked Jul 31, 2026
Check price at Axon Chems →Particle Peptides
Tracked$35.14 / 5mg($70.28 to 10mg)
Checked Jul 24, 2026
Check price at Particle Peptides →Chameleon Peptides
Tracked$36.00 / 5mg($72.00 to 10mg)
Checked Jul 31, 2026
Check price at Chameleon Peptides →Peptide Giants
Tracked$73.69 / 10mg($73.69 to 10mg)
Checked Aug 1, 2026
Check price at Peptide Giants →Polar Peptides
Tracked$75.59 / 10mg($75.59 to 10mg)
Checked Apr 17, 2026
Check price at Polar Peptides →Noble Sciences
Tracked$39.00 / 5mg($78.00 to 10mg)
Checked Aug 1, 2026
Check price at Noble Sciences →Atomik Labz
Tracked$39.00 / 5mg($78.00 to 10mg)
Checked Aug 4, 2026
Check price at Atomik Labz →Puratek Peptides
Tracked$39.95 / 5mg($79.90 to 10mg)
Checked Jul 31, 2026
Check price at Puratek Peptides →Everest Peptides
Tracked$39.99 / 5mg($79.98 to 10mg)
Checked Jul 28, 2026
Check price at Everest Peptides →Hydro Research
Tracked$40.00 / 5mg($80.00 to 10mg)
Checked Jun 5, 2026
Check price at Hydro Research →Pepsynth Labs
Tracked$40.00 / 5mg($80.00 to 10mg)
Checked Aug 7, 2026
Check price at Pepsynth Labs →Evolve Peptides
Tracked$80.00 / 10mg($80.00 to 10mg)
Checked Apr 22, 2026
Check price at Evolve Peptides →$41.00 / 5mg($82.00 to 10mg)
Checked Apr 16, 2026
Check price at Core Peptides →Offline Peptides
Tracked$43.00 / 5mg($86.00 to 10mg)
Checked Jul 28, 2026
Check price at Offline Peptides →Polar Peptides
Tracked$43.19 / 5mg($86.38 to 10mg)
Checked Apr 17, 2026
Check price at Polar Peptides →$44.00 / 5mg($88.00 to 10mg)
Checked May 14, 2026
Check price at Biotech Peptides →True Research Labs
Tracked$44.00 / 5mg($88.00 to 10mg)
Checked Aug 15, 2026
Check price at True Research Labs →SKO Compounds
Tracked$89.99 / 10mg($89.99 to 10mg)
Checked Jul 23, 2026
Check price at SKO Compounds →Onyx Research
Tracked$45.00 / 5mg($90.00 to 10mg)
Checked Apr 6, 2026
Check price at Onyx Research →PeakForm Peptides
Tracked$45.00 / 5mg($90.00 to 10mg)
Checked Aug 1, 2026
Check price at PeakForm Peptides →Liv Pure Wellness
Tracked$90.00 / 10mg($90.00 to 10mg)
Checked Apr 14, 2026
Check price at Liv Pure Wellness →Apex Peptides
Tracked$90.00 / 10mg($90.00 to 10mg)
Checked Jul 31, 2026
Check price at Apex Peptides →CertaPeptides
Tracked$45.56 / 5mg($91.12 to 10mg)
Checked Jun 27, 2026
Check price at CertaPeptides →Durham Peptides
Tracked$46.36 / 5mg($92.72 to 10mg)
Checked Aug 7, 2026
Check price at Durham Peptides →Glacier Aminos
Tracked$92.99 / 10mg($92.99 to 10mg)
Checked Jul 31, 2026
Check price at Glacier Aminos →Purus Peptides
Tracked$49.00 / 5mg($98.00 to 10mg)
Checked Aug 6, 2026
Check price at Purus Peptides →Peptide Giants
Tracked$49.49 / 5mg($98.98 to 10mg)
Checked Aug 1, 2026
Check price at Peptide Giants →Swift Peptides
Tracked$98.99 / 10mg($98.99 to 10mg)
Checked Aug 6, 2026
Check price at Swift Peptides →Woosh Labs
Tracked$49.99 / 5mg($99.98 to 10mg)
Checked Jun 24, 2026
Check price at Woosh Labs →Euno Labs Research
Tracked$49.99 / 5mg($99.98 to 10mg)
Checked Jul 25, 2026
Check price at Euno Labs Research →Nationwide Peptides
Tracked$50.00 / 5mg($100.00 to 10mg)
Checked Aug 5, 2026
Check price at Nationwide Peptides →Modern Aminos
Tracked$54.00 / 5mg($108.00 to 10mg)
Checked May 14, 2026
Check price at Modern Aminos →CertaPeptides
Tracked$108.21 / 10mg($108.21 to 10mg)
Checked Jun 27, 2026
Check price at CertaPeptides →Peptide Giants
Tracked$21.99 / 2mg($109.95 to 10mg)
Checked Aug 1, 2026
Check price at Peptide Giants →Swift Peptides
Tracked$54.99 / 5mg($109.98 to 10mg)
Checked Aug 6, 2026
Check price at Swift Peptides →Evolve Peptides
Tracked$55.00 / 5mg($110.00 to 10mg)
Checked Apr 22, 2026
Check price at Evolve Peptides →Optima Supply
Tracked$55.00 / 5mg($110.00 to 10mg)
Checked Aug 3, 2026
Check price at Optima Supply →PeakForce Labs
Tracked$55.00 / 5mg($110.00 to 10mg)
Checked Aug 15, 2026
Check price at PeakForce Labs →Liv Pure Wellness
Tracked$59.99 / 5mg($119.98 to 10mg)
Checked Apr 14, 2026
Check price at Liv Pure Wellness →Orbitrex Peptides
Tracked$59.99 / 5mg($119.98 to 10mg)
Checked Aug 3, 2026
Check price at Orbitrex Peptides →Mile High Compounds
Tracked$59.99 / 5mg($119.98 to 10mg)
Checked Aug 3, 2026
Check price at Mile High Compounds →$64.99 / 5mg($129.98 to 10mg)
Checked Apr 16, 2026
Check price at Ascension Peptides →Evolve Peptides
Tracked$135.00 / 20mg($135.00 to 10mg)
Checked Apr 22, 2026
Check price at Evolve Peptides →Apex Peptides Lab
Tracked$69.00 / 5mg($138.00 to 10mg)
Checked Aug 15, 2026
Check price at Apex Peptides Lab →Nationwide Peptides
Tracked$145.00 / 10mg($145.00 to 10mg)
Checked Aug 5, 2026
Check price at Nationwide Peptides →Offline Peptides
Tracked$32.00 / 2mg($160.00 to 10mg)
Checked Jul 28, 2026
Check price at Offline Peptides →Pantheon Peptides
Tracked$32.40 / 2mg($162.00 to 10mg)
Checked Apr 23, 2026
Check price at Pantheon Peptides →EZ Peptides
Tracked$38.00 / 2mg($190.00 to 10mg)
Checked Aug 13, 2026
Check price at EZ Peptides →PureBio Labs
Tracked$99.99 / 5mg($199.98 to 10mg)
Checked Aug 5, 2026
Check price at PureBio Labs →Hydro Research
Tracked$350.00 / 50mg($350.00 to 10mg)
Checked Jun 5, 2026
Check price at Hydro Research →Alpha Peptides
Tracked$45.75 / 10mg($45.75 to 10mg)
Checked Jul 31, 2026
Check price at Alpha Peptides →Alpha Peptides
Tracked$32.99 / 5mg($65.98 to 10mg)
Checked Jul 31, 2026
Check price at Alpha Peptides →Pepsynth Labs
Tracked$80.00 / 10mg($80.00 to 10mg)
Checked Aug 7, 2026
Check price at Pepsynth Labs →Purity Peptides
Tracked$49.85 / 5mg($99.70 to 10mg)
Checked Jul 16, 2026
Check price at Purity Peptides →Rivn Peptides
Tracked$49.99 / 5mg($99.98 to 10mg)
Checked Aug 14, 2026
Check price at Rivn Peptides →EZ Peptides
Tracked$53.00 / 5mg($106.00 to 10mg)
Checked Aug 13, 2026
Check price at EZ Peptides →NextGen Peptides
Tracked$200.00 / 50mg($200.00 to 10mg)
Checked Jul 24, 2026
Check price at NextGen Peptides →AOD-9604 price report
AOD-9604 currently costs as little as $40.00 to obtain 10mg, from Cielo Peptides. Across the 58 vendors we track, the typical cost to 10mg is $90.00, using each vendor's own cheapest listing. 55 of those vendors show current stock, and prices were checked through Aug 15, 2026.
- Lowest to 10mg
- $40.00
- Cielo Peptides
- Median to 10mg
- $90.00
- one offer per vendor
- Lowest package
- $21.99
- 2mg at Peptide Giants
- Vendors tracked
- 58
- 55 in stock
Checked through Aug 15, 2026. Prices are aggregated from public vendor listings. Sources and data licensing are documented on our methodology page.
At a glance
- Category
- fat loss
- Mechanism class
- IGF-1 / MGF analog
- Research phase
- Research / preclinical only
- NCAA status
- Banned (NCAA 2025-26 list) — Modified hGH fragment 177-191; banned under NCAA growth hormone entry / WADA S2.1 GH and releasing factors.
- WADA status
- Prohibited (WADA S2 — Peptide Hormones, Growth Factors, Related Substances)
Overview
AOD-9604 is a modified fragment of the C-terminal region (amino acids 176-191) of human growth hormone, engineered by Metabolic Pharmaceuticals Ltd. in Australia in the 1990s to isolate GH's lipolytic (fat-metabolizing) activity while removing its broader growth-promoting and metabolic effects.
Growth hormone fragment peptide (hGH 176-191 modified fragment)
Research timeline
1990s
AOD-9604 developed by Metabolic Pharmaceuticals Ltd. (Australia) as a modified hGH fragment isolating lipolytic activity.
Source →2001-2007
Metabolic Pharmaceuticals conducted six human clinical trials involving over 900 participants evaluating AOD-9604 for obesity management.
Source →circa 2005
Phase IIa trial (12 weeks, 300 participants) reported modest weight reduction of 2.6 kg versus 0.8 kg for placebo.
Source →2007
Phase IIb trial (24 weeks, 536 subjects) found no statistically significant weight-loss difference versus placebo, leading Metabolic Pharmaceuticals to terminate obesity-indication development.
Source →Post-2007
AOD-9604 was licensed for exploration in osteoarthritis research, pivoting away from the obesity indication.
Source →2024
FDA determined AOD-9604 should not be added to the 503A Bulks List for compounding pharmacies, citing limited long-term safety data, peptide impurities, and immunogenicity concerns.
Source →2026
As of April 2026, AOD-9604 is listed as 'Nominated but Withdrawn' from FDA Category 2 nomination status.
Source →
Active & recent research
AOD-9604 Phase IIb obesity trial (completed, negative result)
Weight-loss efficacy versus placebo over 24 weeks in 536 subjects; did not reach statistical significance
AOD-9604 in osteoarthritis research
Investigating a pivot indication after the obesity trial program was discontinued
Key findings
- A 12-week Phase IIa trial (300 participants) reported a modest but statistically distinguishable weight reduction (2.6 kg vs. 0.8 kg placebo), which supported advancement to Phase IIb.
- The subsequent 24-week Phase IIb trial (536 subjects), the largest and most rigorous trial conducted, found no statistically significant difference in weight loss versus placebo, which led directly to program termination in 2007.
- Across all six completed trials (900+ participants), AOD-9604 was reported as well-tolerated with minimal adverse effects; the program failure was attributed to efficacy, not safety.
- The FDA's December 2024 determination against including AOD-9604 on the 503A Bulks List reflects ongoing regulatory concern about limited long-term human safety data even outside the original obesity indication.
Safety & regulatory notes
AOD-9604 is not FDA-approved for any indication. Its formal obesity development program was discontinued in 2007 due to lack of efficacy in the pivotal Phase IIb trial, not due to safety findings. The trials reported it as well-tolerated. However, in December 2024 the FDA declined to add AOD-9604 to the 503A Bulks List used by compounding pharmacies, citing limited long-term safety data, peptide impurity concerns, and potential immunogenicity, and its FDA Category 2 nomination was subsequently withdrawn.
We may earn a commission when readers buy through links on this page, at no extra cost to you. Commissions never affect a vendor's score. Every vendor is graded on the same public rubric built from published lab documentation, live catalog pricing, and community sentiment. How we score →
Where it's sold for research
We haven't built a dedicated vendor-availability page for AOD-9604 yet. See our full research-peptide vendor rankings →
AOD-9604 FAQ
Is AOD-9604 FDA-approved for weight loss?+
No. AOD-9604 was never approved by the FDA, EMA, or TGA. Its obesity clinical development program was discontinued in 2007 after a Phase IIb trial failed to show statistically significant weight loss versus placebo.
Why was AOD-9604 development discontinued?+
Development ended for efficacy reasons, not safety: the pivotal Phase IIb trial (536 subjects, 24 weeks) found no statistically significant weight-loss benefit at the tested dose compared with placebo.
Was AOD-9604 considered safe in its trials?+
Across six completed trials with over 900 participants, AOD-9604 was reported as well-tolerated with minimal adverse effects; the program's failure was attributed specifically to lack of efficacy.
What is AOD-9604's current regulatory status?+
As of the FDA's December 2024 determination, AOD-9604 is not included on the 503A Bulks List for pharmaceutical compounding, and its FDA Category 2 nomination has been withdrawn, reflecting ongoing regulatory caution about limited long-term safety data.
Sources for this page (3)
Researched together
Related: all compound research overviews · full price index · research radar · full vendor rankings · methodology